Cardiol Therapeutics raises over US$7M through warrant exercises (NASDAQ:CRDL)
· seekingalpha.com
Cardiol Therapeutics (CRDL) raises $7M via warrant exercises, extending cash runway to H1 2028 and funding Phase III MAVERIC trial & NDA prep.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...